Morningstar

Real-World Evidence [RWE] Demonstrates Repatha’s Long-Term Cardiovascular Benefits

Target RWE, a leader in advancing modern evidence generation for complex clinical and regulatory challenges, today announced the presentation of compelling new findings from the REPATHA-CE study of ...
Yahoo Finance

AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL

THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha ® (evolocumab) achieved ...
STAT

Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. NEW ORLEANS — A cholesterol-lowering injection ...
Investing

Amgen’s Repatha reduces CV events in patients without prior heart attack

THOUSAND OAKS, Calif. - Amgen (NASDAQ:AMGN), a biotechnology giant with a market capitalization of $157.2 billion and 12.88% revenue growth over the last twelve months, announced Friday that its ...
Pharm Exec

Amgen Launches New Direct-To-Patient Program AmgenNow

AmgenNow, a direct-to-patient program, launches with Repatha, following positive Phase III Vesalius-CV trial results showing reduced cardiovascular events. Starting October 6, 2025, AmgenNow will be ...
Seeking Alpha

Amgen to offer Repatha at 60% discount to U.S. consumers

Amgen (NASDAQ:AMGN) said on Monday that it has launched its cholesterol medication, Repatha, directly to consumers in the U.S. at a reduced cash price. This move comes as part of a broader response ...
Investing

Amgen makes Repatha available at nearly 60% discount via direct program

Repatha is a human monoclonal antibody that inhibits PCSK9, a protein that regulates LDL cholesterol levels in the bloodstream. The medication is approved in more than 74 countries for reducing ...
Healio

Repatha made available via direct-to-patient program at discounted price

Please provide your email address to receive an email when new articles are posted on . Evolocumab will be made available to eligible patients via a new direct-to-consumer program. The PCSK9 inhibitor ...
STAT

Amgen says its cholesterol shot prevented heart problems in a broad population

Matthew Herper covers medical innovation — both its promise and its perils. Amgen said Thursday that its cholesterol-lowering shot, Repatha, prevented a composite of heart disease death, heart attack, ...
WebMD

What Is Repatha, and Why Does It Matter?

Repatha (evolocumab) is an injectable medicine that helps lower levels of low-density lipoprotein cholesterol (LDL), often called “bad” cholesterol. Approved in 2015, Repatha can now be used in adults ...
Pharmabiz

Amgen’s Repatha receives US FDA approval for adults at increased risk for MACE due to uncontrolled LDL-C

Amgen, a biotechnology company that discovers, develops, manufactures and delivers innovative medicines, announced that the US Food and Drug Administration (FDA) has broadened the approved use of ...